发明名称 |
Controlled release pharmaceutical composition |
摘要 |
A solid, controlled release, pharmaceutical composition comprising an active ingredient incorporated in a matrix comprising a first substance selected from a water soluble polydextrose and a water soluble cyclodextrin and a second substance selected from a C12-C36 fatty alcohol and a polyalkylene glycol. Preferably the first substance is a cyclodextrin, especially a beta-cyclodextrin, while the second substance is a C14-C22 fatty alcohol, especially stearyl alcohol, cetyl alcohol, cetostearyl alcohol or myristyl alcohol. The matrix may also contain a cellulose ether, especially a hydroxyalkylcellulose or a carboxyalkylcellulose.
|
申请公布号 |
US4834985(A) |
申请公布日期 |
1989.05.30 |
申请号 |
US19870052585 |
申请日期 |
1987.05.19 |
申请人 |
EUROCELTIQUE S.A. |
发明人 |
ELGER, GORDON;LESLIE, STEWART T.;MALKOWSKA, SANDRA T. A.;MILLER, RONALD B.;NEALE, PHILIP J. |
分类号 |
A61K47/10;A61K9/20;A61K9/22;A61K47/00;A61K47/08;A61K47/36;A61K47/40 |
主分类号 |
A61K47/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|